Q4 2025 Oscar Health Inc Earnings Call Transcript
Key Points
- Oscar Health Inc (OSCR) reported a 28% year-over-year increase in total revenue, reaching $11.7 billion.
- The company improved its SG&A expense ratio by approximately 160 basis points, reflecting efficiency gains through AI and technology advancements.
- Oscar Health Inc (OSCR) achieved a record high membership of 3.4 million as of February 1, 2026, with a 58% increase year-over-year.
- The company expanded its market share from 17% in 2025 to 30% in 2026, indicating strong competitive positioning.
- Oscar Health Inc (OSCR) is on track to return to profitability in 2026, with an expected significant improvement of nearly $750 million in earnings from operations.
- The medical loss ratio (MLR) increased by 570 basis points year-over-year to 87.4%, indicating higher medical costs.
- Oscar Health Inc (OSCR) reported a loss from operations of $396 million in 2025, primarily due to higher market morbidity and risk adjustment payable.
- The company experienced a net loss of $443 million in 2025, driven by higher-than-expected claims and lower-than-expected risk adjustment offset.
- Oscar Health Inc (OSCR) anticipates elevated churn in 2026, particularly among passively enrolled members facing higher premiums.
- The expiration of enhanced premium tax credits and CMS program integrity initiatives are expected to drive market contraction, impacting membership retention.
Good morning. My name is Jenny, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's Fourth Quarter and Full Year 2025 Earnings Conference Call. (Operator Instructions) I will now turn the call over to Chris Potochar, Vice President of Treasury and Investor Relations.
Good morning, everyone. Thank you for joining us for our fourth quarter and full year 2025 earnings call. Mark Bertolini, Oscar Health's Chief Executive Officer; and
This call can also be accessed through our Investor Relations website at ir.hioscar.com. Full details of our results and additional management
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
